Academic Journals Database
Disseminating quality controlled scientific knowledge

Morbid Anxiety as a Risk Factor in Patients with Somatic Diseases: A Review of Recent Findings

ADD TO MY LIST
 
Author(s): Christer Allgulander

Journal: European Neurological Journal
ISSN 2041-8000

Volume: 2;
Issue: 1;
Start page: 31;
Date: 2010;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: anxiety disorders | stroke | diabetes | COPD | pain | IBS | SLE

ABSTRACT
This review focuses on anxiety in patients with somatic diseases, based on studies published from 2007 through January 2010. It covers neurological, cardiovascular, respiratory, and endocrine diseases as well as HIV/AIDS, trauma, skin conditions, and other somatic diseases. Anxiety may be an acute and adequate reaction to receiving a diagnosis of a disabling or life-threatening disease. It may also be precipitated by stroke, injury, or the distress of having to manage diabetes or AIDS. Several studies show that anxious patients inflate self-perceived health problems and are more sensitive to physical symptoms in a manner disproportionate to objective disease validators. Therefore, intervention should be reserved for those patients most likely to benefit from reduced anxiety, improved management of the somatic condition, and improved functioning.This issue is particularly important for the elderly, who represent a growing global challenge. Late-onset anxiety may be caused by loneliness and bereavement, and can be compounded by immobilization and somatic disease. Controlled treatment studies of anxiolytics as well as their potential benefits in the overall management of anxious patients with somatic disease are generally lacking. Research to determine the benefits and costs of such treatments in primary and tertiary care is currently underway.
RPA Switzerland

RPA Switzerland

Robotic process automation

    

Tango Rapperswil
Tango Rapperswil